Related Experiment Video
Updated: Jan 8, 2026

Methods for In Vivo Biomechanical Testing on Brachial Plexus in Neonatal Piglets
Published on: December 19, 2019
Magnesium in brachial plexus blocks: A meta-analysis, meta regression, and trial sequential analysis
Sushil Pal1, Rasmeet Kaur Kainth2, Rajiv Malhotra3
1ST5 Resident Doctor, Department of Anaesthesia, Royal Liverpool University Hospital, UK.
Background And Aims:
Evidence is inconclusive regarding the role of magnesium sulphate (MgSO4) on the onset of sensory block in brachial plexus blocks (BPBs). A meta-analysis was conducted to assess the impact of adding MgSO4 to local anaesthetics (LA) used in BPBs on the onset time of sensory block.
Methods:
Medline, Embase, Google Scholar, and bibliography searches were consulted to identify randomised clinical trials using MgSO4 versus control in BPBs. The primary outcome was the onset of sensory block. The secondary outcomes measured were duration of sensory and motor block, as well as the duration of analgesia. Continuous data were expressed as standard mean difference (SMD) with 95% confidence intervals (CI) and analysed using a random-effects model. Subgroup analysis was also performed based on magnesium dose. Study quality was assessed using a JADAD scoring system.
Results:
Thirty-two studies were included in this study. MgSO4 led to a quicker onset of sensory block (n = 1768; N = 28; SMD = -1.00; 95% CI: -1.46, -0.55; P < 0.0001). MgSO4 also led to a quicker onset of motor block (n = 1768; N = 28; SMD = -1.15; 95% CI: -1.62, -0.68; P < 0.00001), and prolonged duration of analgesic effect (n = 1368; N = 21; SMD = 4.22; 95% CI: 3.36, 5.08; P < 0.00001). Subgroup analysis showed that MgSO4 doses of >200 mg compared to ≤200 mg prolonged the duration of sensory block (MD = 179.00 min vs 144.31 min) and motor block (MD = 145.26 min vs 116.52 min). It also showed that MgSO4 >200 mg led to a longer duration of analgesia compared to MgSO4 ≤200 mg (MD = 231.65 min vs 173.58 min).
Conclusion:
Using MgSO4 as an adjunct to LA in BPBs leads to a faster onset of sensory block. MgSO4 also prolongs the duration of analgesia, with optimal doses likely being ≤200 mg.
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Skeletal Muscle Relaxants: Therapeutic Uses

